Home > PE Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BALAXI PHARMACEUTICALS is 11.45.

Share Price ₹52.0Jun 13,2025
Market Cap ₹287.0 Cr
Earnings-TTM₹25.1 CrTTM-Consolidated Results
Price/Earnings11.45xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹287.0 Cr] as on Jun 13,2025

(/) Earnings [ ₹25.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 11.45x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 11.45 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS


PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 11.45x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.11x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BALAXI PHARMACEUTICALS 25.0711.45287.0
ADANI ENTERPRISES LTD7,510.2238.52289,313.0
REDINGTON LTD1,820.6212.6723,074.1
MMTC LTD69.53150.0410,432.5
HONASA CONSUMER LTD72.69137.349,983.1
LLOYDS ENTERPRISES LTD126.3074.459,403.6
ENTERO HEALTHCARE SOLUTIONS LTD107.4348.365,195.0
OPTIEMUS INFRACOM LTD60.0088.345,300.2
POLO QUEEN INDUSTRIAL & FINTECH LTD2.64763.102,013.8
MSTC LTD435.688.543,721.7
SG MART LTD103.4048.495,014.2

Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 8.54x
Max industry PE 763.10x
Median industry PE 48.49x
Average industry PE 125.58x



You may also like the below Video Courses